Cargando…

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease

SIMPLE SUMMARY: Since the knowledge of tumor biology has advanced, a variety of targeted therapies has been developed. These do not immediately affect the tumor size, so optimized oncological imaging is needed. In this phase I study of patients with advanced malignant disease, a multiparametric imag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerwing, Mirjam, Krähling, Tobias, Schliemann, Christoph, Harrach, Saliha, Schwöppe, Christian, Berdel, Andrew F., Klein, Sebastian, Hartmann, Wolfgang, Wardelmann, Eva, Heindel, Walter L., Lenz, Georg, Berdel, Wolfgang E., Wildgruber, Moritz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657298/ https://www.ncbi.nlm.nih.gov/pubmed/34884988 http://dx.doi.org/10.3390/cancers13235880

Ejemplares similares

First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
por: Schliemann, Christoph, et al.
Publicado: (2020)

Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
por: Berdel, Wolfgang E., et al.
Publicado: (2020)

Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR
por: Höink, Anna, et al.
Publicado: (2019)

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
por: Berdel, Andrew F., et al.
Publicado: (2021)

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma
por: Brand, Caroline, et al.
Publicado: (2020)

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
por: Kessler, Torsten, et al.
Publicado: (2018)

Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
por: Stucke-Ring, Janine, et al.
Publicado: (2016)

NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor
por: Brand, Caroline, et al.
Publicado: (2016)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)(3)-tTF
por: Huang, Zheng-jie, et al.
Publicado: (2013)

Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor
por: LIERSCH, RUEDIGER, et al.
Publicado: (2012)

Multiparametric MRI enables for differentiation of different degrees of malignancy in two murine models of breast cancer
por: Gerwing, Mirjam, et al.
Publicado: (2022)

Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy
por: Hoffmann, Emily, et al.
Publicado: (2023)

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2019)

Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy
por: Hoffmann, Emily, et al.
Publicado: (2023)

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
por: Berdel, Andrew F., et al.
Publicado: (2022)

Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
por: Angenendt, Linus, et al.
Publicado: (2020)

NGR-peptide−drug conjugates with dual targeting properties
por: Enyedi, Kata Nóra, et al.
Publicado: (2017)

Unintended Regulatory Caused Early Death—A Difficult Endpoint in Cancer Patient Care and Treatment
por: Berdel, Wolfgang E.
Publicado: (2021)

Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe
por: Berdel, Wolfgang E.
Publicado: (2022)

Intra-arterial catheter-directed CT angiography for assessment of endovascular aortic aneurysm repair
por: Usai, Marco V., et al.
Publicado: (2019)

Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy
por: Gerwing, M., et al.
Publicado: (2023)

Multispectral Optoacoustic Tomography: Intra- and Interobserver Variability Using a Clinical Hybrid Approach
por: Helfen, Anne, et al.
Publicado: (2019)

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases
por: Schliemann, Christoph, et al.
Publicado: (2018)

Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
por: Bäumer, Nicole, et al.
Publicado: (2022)

Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
por: Klosner, Justine, et al.
Publicado: (2021)

Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis
por: Kuron, David, et al.
Publicado: (2023)

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Tracking of Tumor Cell–Derived Extracellular Vesicles In Vivo Reveals a Specific Distribution Pattern with Consecutive Biological Effects on Target Sites of Metastasis
por: Gerwing, Mirjam, et al.
Publicado: (2020)

RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations
por: Brabetz, Oliver, et al.
Publicado: (2017)

Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward – a retrospective analysis
por: Kampmeier, Stefanie, et al.
Publicado: (2017)

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling
por: Valentinis, Barbara, et al.
Publicado: (2019)

Targeting Serum Glucocorticoid-Regulated Kinase-1 in Squamous Cell Carcinoma of the Head and Neck: A Novel Modality of Local Control
por: Berdel, Henrik O., et al.
Publicado: (2014)

Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth
por: Bäumer, Nicole, et al.
Publicado: (2018)

NgR1 and NgR3 are Receptors for Chondroitin Sulfate Proteoglycans
por: Dickendesher, Travis L., et al.
Publicado: (2012)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
por: Corti, Angelo, et al.
Publicado: (2013)

Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2018)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m59rilt9prnrlsdvfg8ho7gk2t